• Profile
Dr. Niwrutti Hase
Dr. NK Hase delivers a masterclass on urinary tract infections (UTIs), exclusive for M3 India members, in this 3-part series. In this first part, he discusses classification, pathogenesis, and microbiological spectrum of UTIs.
Dr. NK Hase picks major trials and updates in Nephrology from the previous year, that will have significant influence on practice and treatment decisions in 2020.
Fibrillary glomerulonephritis (FGN) is a rare disease with unknown aetiopathogenesis. Electron microscopy has been the only method to establish diagnosis. However, now, DNAJB9 can help with diagnosis of FGN with 99-100% sensitivity. Here, Dr. NK Hase writes on the novel tissue biomarker.
Dr. N K Hase shares a review that addresses key points about PLA2R antibodies; a bio marker that has changed nephrologists' practice; the way they diagnose, treat and prognosticate the membranous nephropathy.
M3 app logo
Choose easy access to M3 India from your mobile!

M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen